secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001040130-23-000036
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Q4 sales $62.4M (-5% YoY), net loss $5.1M; acquires PetCareRx, declares $0.30 dividend
--------------------------------------------------------------------------------

- Q4 sales $62.4M (-5% YoY); net loss $5.1M ($0.25 loss per share) vs net income $6.1M last year.
- Accrued $6.9M sales tax liability; adjusted EBITDA $3.6M vs $9.5M prior year.
- New customers up 12% YoY to ~72,000; Autoship & Save revenue 44% of sales (vs 31% last year).
- Completed PetCareRx acquisition for $36M cash; expects it to be accretive by end of fiscal year.
- Declared $0.30 per share cash dividend payable in June 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000036/0001040130-23-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000036/pets-20230522.htm
  HTML page:      https://secwatch.observer/filing/0001040130-23-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer